Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study

Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study

Autor Kaari, Cristina Autor UNIFESP Google Scholar
Haidar, Mauro Abi Autor UNIFESP Google Scholar
Soares Junior, Jose Maria Autor UNIFESP Google Scholar
Nunes, Marcia Gaspar Autor UNIFESP Google Scholar
Quadros, Luis Gerk de Azevedo Autor UNIFESP Google Scholar
Kemp, Claudio Autor UNIFESP Google Scholar
Stavale, Joao Norberto Google Scholar
Baracat, Edmund Chada Autor UNIFESP Google Scholar
Instituição Universidade Federal de São Paulo (UNIFESP)
Resumo Objective: the aim of this study was to evaluate the effects of isoflavone on the climacteric symptoms (Kupperman Menopausal index), vaginal pH, vaginal cytology (vaginal maturation index) and endometrium (evaluated by ultrasound and biopsy) in postmenopausal women.Methods: It was a single-center, 6-month, randomized, double-blind, estrogen-controlled trial. Seventy-nine women were randomly assigned to one of the two treatment groups: isoflavone (n = 40): 300 mg of the standardized soy extract with a medium dose of 120 mg isoflavones/day as glycoside and aglycone (60 mg twice a day), or estrogen (n = 39): one capsule of 0.625 mg conjugated equine estrogens and other capsule with glucose 0.625 mg (placebo).Results: After treatment, there was a decrease in the symptomatology in both estrogen and isoflavone groups. There was a significant decrease in vaginal pH, an increase in superficial vaginal cells and endometrium proliferation after 3 and 6 months of treatment in the estrogen group, but no differences were observed in the isoflavone group for these variables.Conclusions: We concluded that the daily standardized soy extract with 120 mg isoflavones' effect on symptoms was similar to that from estrogen. Soy isoflavone has no effect on endometrium and vaginal mucosa during the treatment. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
Assunto isoflavone
postmenopausal women
hormone therapy
Idioma Inglês
Data 2006-01-10
Publicado em Maturitas. Clare: Elsevier B.V., v. 53, n. 1, p. 49-58, 2006.
ISSN 0378-5122 (Sherpa/Romeo, fator de impacto)
Editor Elsevier B.V.
Extensão 49-58
Fonte http://dx.doi.org/10.1016/j.maturitas.2005.02.009
Direito de acesso Acesso aberto Open Access
Tipo Artigo
Web of Science WOS:000234640100007
URI http://repositorio.unifesp.br/handle/11600/28690

Mostrar registro completo

Arquivos deste item

Arquivos Tamanho Formato Visualização

Não existem arquivos associados a este item.

Este item aparece na(s) seguinte(s) coleção(s)